Life Sciences

AI Startup AliveCor Delivers Remote Cardiac Monitoring

Let’s face it: Most of us aren’t big fans of going to the doctor. It’s usually the last option after you’ve started pissing blood or got a really painful hangnail. In the Age of Rona, some people would rather die than seek medical help. Literally. As early as April, emergency room visits dropped 42% across […]

GenapSys Finally Commercializes Desktop DNA Sequencer

Good things come to those who wait, but we’re an impatient bunch here at Nanalyze. It’s no wonder that we decided to write about disruptive technology rather than spend the time actually creating it. Consider that it took an international team of scientists 13 years and $3 billion to map the genes that comprise the […]

The Future of Life Sciences is Laboratory Automation

“If it flies, floats, or fornicates, always rent it. It’s cheaper in the long run.” That’s one of the many gems of wisdom you’ll find in the book How to Get Rich by U.K. entrepreneur Felix Dennis. If he were alive today, Mr. Dennis might add lab equipment to the list of things that should […]

Why is Illumina’s Stock Price Falling?

Fewer than half of Americans own a passport. Some say that’s because their own backyard is such a big one. The half of our audience that hails from there may not be aware of what’s happening with global travel because they’re blissfully watching the stock market soar inexplicably. According to the World Tourism Barometer, international […]

Biodesix – A Lung Cancer Diagnostics Stock

One can’t help but wonder why the Americans are so worried about peanut allergies when 34 million of them use a product every day that slowly kills them. In the United States, cigarette smoking is linked to about 80% to 90% of lung cancer deaths. While we may not be able to pry someone’s cigarettes from their […]

Augmedix Stock – A Remote Clinical Documentation IPO

We don’t usually do this sort of stuff, but we’d like to start this article off letting everyone know about an exciting SPAC opportunity. John from Cameroon – a region in the great country of Africa – emailed us about a pre-revenue cosmetics/wood timber/software development outsourcing company that’s looking for a SPAC to have an […]

When Did Organs-on-a-Chip Become Human-on-a-Chip?

Drug discovery is one of the keystone themes we cover on Nanalyze, and we’re not just talking about finding new cannabis dispensaries in the smoking Pacific Northwest. Creating novel medicines from scratch to treat disease isn’t cheap. A study published this year calculated it costs an average of $1.3 billion to develop a new drug […]

Grail – A Pure-Play Stock For Cancer Blood Testing

Wasn’t even 48 hours ago that we were commenting on how one of Illumina’s big venture bets – Grail – didn’t seem to be doing much. And here we are today, poring over their S-1 filing as the Illumina-backed venture has just filed for an Initial Public Offering (IPO). Since we’re long Guardant (GH) given […]

A Liquid Biopsy Stock That’s Going Places

The so-called “cure for cancer” isn’t one magical treatment that may or may not be secretly hidden from everyone as part of a vast conspiracy by big pharma. Today’s spray-and-pray approach to cancer treatment has varying degrees of success targeting the over 200 types of cancer, each instance of which is unique to the patient. […]

Kernel Offers Brain-Computer Interface as a Service

This year we learned about a mind-blowing advance in brain-computer interface (BCI) technology for recording and interpreting neural signals. Founded by a wealthy and outsized personality, the West Coast startup has raised more than $100 million to advance the boundaries of neuroscience, augment human memory, and perhaps meld mind and machine in mind-bending ways. You […]